Results 41 to 50 of about 3,498 (121)

Zollinger-Ellison syndrome: a case report

Zdravniški Vestnik, 2006
Background: Zollinger-Ellison syndrome is the consequence of excessive and autonomous secretion of gastrin from gastrinoma cells. The disease is exceptionally rare and characterized by severe and treatment-resistant peptic disease that can become life ...
Mitja Krajnc, Miro Čokolič
doaj  

Immunological insights into gastric polyps: pathogenesis, inflammation and neoplastic potential

Clinical &Translational Immunology, Volume 15, Issue 4, 2026.
Abstract Gastric polyps are a heterogeneous group of mucosal lesions increasingly detected during routine endoscopy, encompassing entities with distinct pathogenesis, immune landscapes and variable malignant potential. Accumulating evidence highlights the central role of gastric mucosal immunity in driving polyp initiation, progression, and, in select ...
Kshitija Kale, Pranav S. Renavikar, Anjali D. Amarapurkar   +2 more
wiley   +1 more source

Etiology and Therapeutic Strategies for Refractory Peptic Ulcers: A Comprehensive Review [PDF]

The Korean Journal of Helicobacter and Upper Gastrointestinal Research
The leading causes of refractory peptic ulcers are Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs. Additionally, insufficient treatment for the suppression of gastric acid, smoking, alcohol consumption, and concomitant diseases ...
Su Bee Park
doaj   +1 more source

A Case of Gastric Neuroendocrine Tumor With a Raspberry‐Like Appearance on the Background of Acid‐Suppressive Therapy‐Related Gastropathy

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT We report the case of a 52‐year old man who was referred to our institution after a routine health check identified an asymptomatic gastric polyp. The medical history of the patient included reflux esophagitis, for which he had been treated with vonoprazan 10 mg daily for 6 years after initially receiving proton pump inhibitors.
Yoshiaki Moriguchi, Jun Nakahodo, Mari Iseki, Toshihiro Funabiki, Yasuhiro Oka, Eriko Noma, Takeo Arakawa, Shin‐ichiro Horiguchi, Osamu Goto, Toshiro Iizuka   +9 more
wiley   +1 more source

Prescription Behaviour and Drug Interactions of Acid Suppressants With Tyrosine Kinase Inhibitors in Patients With Leukaemia: Data From Germany

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Tyrosine kinase inhibitors (TKIs) are essential in treating chronic myeloid leukaemia (CML) and other malignancies. Their absorption, however, is highly pH‐dependent, making them susceptible to interactions with acid‐suppressing agents such as proton pump inhibitors (PPIs), histamine‐2 receptor antagonists (H2RAs) and antacids ...
Marek Lapka, Anna Khryakova, Anastasiia Nazmutdinova, Chrysostomos Charalambous, Jan Bosak, Jiri Sliva   +5 more
wiley   +1 more source

Endoscopic Ultrasound for the Management of Pancreatic Neuroendocrine Tumors: Diagnosis, Treatment, and Future Perspectives

Journal of Gastroenterology and Hepatology, Volume 41, Issue 4, Page 1173-1190, April 2026.
ABSTRACT Pancreatic neuroendocrine tumors (PanNETs) are increasingly diagnosed, reflecting greater clinical awareness, improved imaging, and revised classification. This review summarizes evidence on epidemiology, diagnostic workup, and endoscopic ultrasound (EUS)–guided management of PanNETs, encompassing diagnostic evaluation, tissue acquisition, and
Angelo Bruni, David Meacci, Roberto Falbo, Marco Fichera, Francesco Poggioli, Riccardo Casadei, Claudio Ricci, Leonardo Henry Eusebi   +7 more
wiley   +1 more source

Psychosocial Outcomes in Patients With Endocrine Tumor Syndromes: A Systematic Review

Pediatric Blood &Cancer, Volume 73, Issue 3, March 2026.
ABSTRACT Introduction The combination of disease manifestations, the familial burden, and varying penetrance of endocrine tumor syndromes (ETSs) is unique. This review aimed to portray and summarize available data on psychosocial outcomes in patients with ETSs and explore gaps and opportunities for future research and care.
Daniël Zwerus, Floortje Strobbe, Annemarie A. Verrijn Stuart, Hanneke M. van Santen, Gerlof D. Valk, Sasja A. Schepers, Rachel S. van Leeuwaarde   +6 more
wiley   +1 more source

Omeprazole: Inhibiting the Final Common Pathway to Acid Secretion - The Acid Pump

Canadian Journal of Gastroenterology, 1989
Omeprazole is the first agent in a new therapeutic advance class the proton or acid pump inhibitors which represents a significant therapeutic advance in the treatment of acid related diseases.
A.B.R. Thomson
doaj   +1 more source

De novo Gastrinoma: A Case Report

GE: Portuguese Journal of Gastroenterology, 2019
Gastrinomas are neuroendocrine tumors characterized by gastrin overexpression – 80% are sporadic and 20% are associated with multiple endocrine neoplasia type 1.
Arsénio Barbosa, Filipa Gomes, Luísa Fonseca, Tiago Maia, Jorge Almeida   +4 more
doaj   +1 more source

Somatostatin receptor molecular imaging in a misdiagnosed gastrinoma case

World Journal of Nuclear Medicine, 2020
Gastrin-secreting tumors, hypergastrinemia and severe ulcer disease form the trademarks of Zollinger-Ellison syndrome (ZES). We report a case of gastrinoma, in a patient who was misdiagnosed for almost five years.
Cati Stolniceanu, Irena Grierosu, Milovan Matovic, Cipriana Stefanescu   +3 more
doaj   +1 more source